Clinical Trial Detail

NCT ID NCT04390243
Title Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United
Indications

pancreatic cancer

Therapies

Binimetinib + Encorafenib

Age Groups: senior adult

Additional content available in CKB BOOST